V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002526 | 330001394 | 1.85 | 78.85 | Curative (C) | null | 2017-02-25 | Rituximab | N | Y | 330009372 | RITUXIMAB |
| 330002527 | 330001394 | 1.78 | 84.1 | Curative (C) | 2015-03-26 | 2015-04-03 | CNS GCT II Germinoma - Carbo Etop | N | N | 330009372 | CARBOPLATIN + ETOPOSIDE |
| 330002528 | 330001394 | 1.79 | 75.8 | Palliative (P) | 2017-08-31 | 2017-09-08 | Carboplatin AUC 6 - 10 | N | N | 330009372 | CARBOPLATIN |
| 330002529 | 330001394 | 1.57 | 68.2 | Curative (C) | 2016-01-15 | 2016-01-19 | Carboplatin + Etoposide IV 3 day | 02 | null | 330009372 | CARBOPLATIN + ETOPOSIDE |
| 330002530 | 330012118 | 1.73 | 46 | Curative (C) | 2013-12-05 | 2013-12-10 | Carboplatin AUC 6 - 10 | 2 | N | 330009390 | CARBOPLATIN |
| 330002531 | 330001395 | 1.72 | 104.9 | Palliative (P) | 2017-10-26 | 2017-10-29 | Bendamustine+Rituximab (1st Course) | N | N | 330009395 | BENDAMUSTINE + RITUXIMAB |
| 330002532 | 330001396 | 1.6 | 79 | Curative (C) | 2014-01-29 | 2014-01-29 | Carboplatin AUC 2 - 5 | N | N | 330009403 | CARBOPLATIN |
| 330002533 | 330001396 | 1.64 | 98.5 | Palliative (P) | 2015-08-21 | 2015-08-30 | Doxorubicin 75mg/m2 | 2 | null | 330009403 | DOXORUBICIN |
| 330002534 | 330001397 | 1.73 | null | Neo-adjuvant (N) | 2017-01-30 | 2017-01-30 | Cisplatin + Doxorubicin | N | N | 330009418 | CISPLATIN + DOXORUBICIN |
| 330002535 | 330001397 | null | null | null | 2013-08-05 | 2013-08-16 | CARBOPLATIN + PACLITAXEL | N | N | 330009418 | CARBOPLATIN + PACLITAXEL |
| 330002536 | 330009642 | null | 78.6 | null | 2014-11-10 | 2014-11-10 | CNS GCT II Germinoma - Carbo Etop | N | N | 330009422 | CARBOPLATIN + ETOPOSIDE |
| 330002537 | 330009642 | 1.8 | 91.6 | Palliative (P) | 2015-08-06 | 2015-08-10 | Liposomal Doxorubicin (20mg/m2) | N | N | 330009422 | LIPOSOMAL DOXORUBICIN |
| 330002538 | 330001398 | 1.75 | null | Disease modification (D) | 2013-03-04 | 2013-03-04 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330009433 | BENDAMUSTINE + RITUXIMAB |
| 330002539 | 330001398 | null | 79.6 | Palliative (P) | 2015-11-22 | 2015-11-30 | Carboplatin AUC 6 - 10 | N | N | 330009433 | CARBOPLATIN |
| 330002540 | 330009643 | 1.68 | null | Adjuvant (A) | 2015-04-18 | 2015-04-18 | DOXORUBICIN | 02 | Y | 330009438 | DOXORUBICIN |
| 330002541 | 330009643 | 1.72 | 77.75 | Curative (C) | 2013-01-30 | 2013-01-30 | Bendamustine+Rituximab (1st Course) | 2 | N | 330009438 | BENDAMUSTINE + RITUXIMAB |
| 330002542 | 330009643 | 1.65 | 101 | Palliative (P) | null | 2017-03-28 | CARBOPLATIN + ETOPOSIDE | N | N | 330009438 | CARBOPLATIN + ETOPOSIDE |
| 330002543 | 330009643 | 1.77 | 90.8 | Disease modification (D) | 2015-05-18 | 2015-05-28 | Rituximab | 2 | N | 330009438 | RITUXIMAB |
| 330002544 | 330001399 | 1.68 | 93.5 | Palliative (P) | 2016-05-21 | 2016-05-24 | Carboplatin + Etoposide IV 3 day | N | N | 330009446 | CARBOPLATIN + ETOPOSIDE |
| 330002545 | 330001400 | 1.76 | 73 | Neo-adjuvant (N) | 2016-11-29 | 2016-11-16 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330009450 | CARBOPLATIN + PACLITAXEL |
| 330002546 | 330001401 | 1.68 | 8.3 | Palliative (P) | 2017-10-26 | 2017-10-26 | Rituximab | 02 | N | 330009451 | RITUXIMAB |
| 330002547 | 330006737 | 1.7 | 88.9 | Palliative (P) | 2013-11-26 | 2014-08-14 | Carboplatin + Etoposide iv&po | 2 | Y | 330009502 | CARBOPLATIN + ETOPOSIDE |
| 330002548 | 330001402 | 1.64 | 85 | Curative (C) | 2019-02-13 | 2019-02-13 | Carboplatin + Etoposide iv&po | N | N | 330009550 | CARBOPLATIN + ETOPOSIDE |
| 330002550 | 330001404 | 1.71 | 52 | Palliative (P) | 2015-12-08 | 2015-12-08 | BENDAMUSTINE + RITUXIMAB | 02 | null | 330009673 | BENDAMUSTINE + RITUXIMAB |
| 330002552 | 330001405 | 1.77 | 65.6 | null | 2014-12-19 | 2014-12-19 | Rituximab | 02 | null | 330009693 | RITUXIMAB |
| 330002553 | 330001405 | null | null | Palliative (P) | null | 2013-12-08 | CNS GCT II Germinoma - Carbo Etop | N | N | 330009693 | CARBOPLATIN + ETOPOSIDE |
| 330002554 | 330001406 | 1.78 | 86 | Palliative (P) | 2015-12-08 | 2015-12-15 | DOXORUBICIN | N | N | 330009711 | DOXORUBICIN |
| 330002555 | 330001407 | 1.79 | 113 | Curative (C) | 2017-09-20 | 2017-09-22 | CARBOPLATIN + ETOPOSIDE | 2 | N | 330009744 | CARBOPLATIN + ETOPOSIDE |
| 330002556 | 330006740 | 1.79 | 57.7 | Disease modification (D) | 2015-09-09 | 2015-09-12 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330009749 | CARBOPLATIN + PACLITAXEL |
| 330002557 | 330001408 | null | 63 | Palliative (P) | 2016-07-08 | 2016-07-28 | Liposomal Doxorubicin (Caelyx) | N | null | 330009753 | LIPOSOMAL DOXORUBICIN |
| 330002558 | 330006741 | 1.57 | 78.3 | Palliative (P) | null | 2015-06-23 | CARBOPLATIN + ETOPOSIDE | N | N | 330009847 | CARBOPLATIN + ETOPOSIDE |
| 330002559 | 330001409 | 1.73 | null | Neo-adjuvant (N) | 2016-09-27 | 2016-10-05 | Cisplatin + Doxorubicin | 02 | N | 330009871 | CISPLATIN + DOXORUBICIN |
| 330002560 | 330001410 | null | 117.8 | Not known (9) | 2016-09-15 | 2016-09-17 | DOXORUBICIN | 02 | N | 330009891 | DOXORUBICIN |
| 330002561 | 330006742 | 1.73 | 97.9 | Disease modification (D) | 2013-10-10 | 2013-10-10 | Rituximab (Maintenance) | 2 | Y | 330009995 | RITUXIMAB |
| 330002562 | 330006742 | 1.7 | 62.8 | Curative (C) | 2017-12-22 | 2018-01-06 | Rituximab | N | N | 330009995 | RITUXIMAB |
| 330002563 | 330006742 | null | 80.5 | Palliative (P) | 2017-07-07 | 2017-07-07 | Rituximab | null | N | 330009995 | RITUXIMAB |
| 330002564 | 330006742 | 1.8 | 83.3 | Palliative (P) | 2014-03-03 | 2014-03-03 | Carboplatin AUC 2 - 5 | 2 | N | 330009995 | CARBOPLATIN |
| 330002565 | 330001411 | 1.46 | 54 | Adjuvant (A) | 2016-01-17 | 2016-01-17 | Cisplatin + Doxorubicin | N | N | 330010198 | CISPLATIN + DOXORUBICIN |
| 330002566 | 330001412 | 1.68 | null | Curative (C) | 2013-06-25 | 2013-06-25 | CARBOPLATIN + ETOPOSIDE | N | N | 330010202 | CARBOPLATIN + ETOPOSIDE |
| 330002567 | 330001412 | 1.61 | 0 | Curative (C) | 2016-01-06 | 2016-01-20 | Carboplatin + Etoposide IV 3 day | N | N | 330010202 | CARBOPLATIN + ETOPOSIDE |
| 330002568 | 330001413 | 1.73 | 95 | Disease modification (D) | 2016-06-29 | 2016-07-13 | Rituximab | N | N | 330010223 | RITUXIMAB |
| 330002569 | 330006744 | 1.77 | 50.2 | Palliative (P) | 2014-03-01 | 2014-03-07 | BENDAMUSTINE + RITUXIMAB | N | N | 330010283 | BENDAMUSTINE + RITUXIMAB |
| 330002570 | 330006744 | 1.65 | 11.7 | Curative (C) | 2014-05-21 | 2014-05-23 | Rituximab (SUBCUTANEOUS Maintenance) | N | null | 330010283 | RITUXIMAB |
| 330002571 | 330006744 | 1.8 | 60 | Curative (C) | 2013-11-01 | 2013-11-18 | Carboplatin AUC 2 - 5 | N | N | 330010283 | CARBOPLATIN |
| 330002572 | 330006744 | 1.63 | 63.4 | Curative (C) | 2015-03-16 | 2015-03-18 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330010283 | CARBOPLATIN + PACLITAXEL |
| 330002573 | 330006744 | 1.7 | null | Neo-adjuvant (N) | null | 2014-08-11 | Cisplatin + Doxorubicin | N | N | 330010283 | CISPLATIN + DOXORUBICIN |
| 330002574 | 330006744 | 1.8 | 69.7 | Curative (C) | 2014-05-10 | 2014-05-10 | Carboplatin AUC 6 - 10 | N | null | 330010283 | CARBOPLATIN |
| 330002575 | 330001414 | 1.54 | 92.8 | Disease modification (D) | 2015-12-16 | 2015-12-21 | Liposomal Doxorubicin (Caelyx) | N | N | 330010451 | LIPOSOMAL DOXORUBICIN |
| 330002576 | 330001415 | 1.6 | 45.2 | Palliative (P) | 2016-06-18 | 2016-07-03 | Liposomal Doxorubicin (20mg/m2) | 02 | Y | 330010452 | LIPOSOMAL DOXORUBICIN |
| 330002577 | 330001416 | 1.68 | 73.7 | Neo-adjuvant (N) | 2016-02-28 | 2016-02-28 | Carboplatin AUC 2 - 5 | 02 | null | 330010456 | CARBOPLATIN |